Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Welmed Pharmaceutical Industries (Pvt) Ltd.

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx65product presentations
G32generic molecules
DF9dosage-form groups
TA3therapeutic areas
PKR65current price records
REG60registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage92%
priced packs safely normalized per unit
Comparable-market coverage91%
products with at least one like-for-like comparator
Portfolio intelligence

Therapeutic mix

Unclassified59 products · 91%
Third-generation cephalosporins3 products · 5%
Fluoroquinolone antibacterials2 products · 3%
Proton pump inhibitors1 products · 2%
Formulation footprint

Dosage forms

Tablet31 products
Suspension10 products
Injection8 products
Capsule6 products
Cream5 products
Syrup2 products
Drops1 products
Gel1 products
Sachet1 products
Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 ZitamedAzithromycin 7presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet, Capsule #2 LorymedLevetiracetam 4presentations 250 mg, 500 mg · Tablet #3 MedrispRisperidone 4presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet #4 RaxmedClarithromycin 3presentations 250 mg, 250 mg/5 mL, 500 mg · Tablet, Suspension #5 ShelzonCeftriaxone 3presentations 1000 mg, 250 mg, 500 mg · Injection #6 Ze-XimCefixime 3presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg · Suspension, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1322% of comparable products
Near market median38within ±5% of median
Above market median814% of comparable products
Lowest-price equivalents2ties included
Company median price position -0.6% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Pine 100 mgQuetiapine · Tablet · 10*s PKR 35.58/tablet-49.8% vs market median Lorymed 500 mgLevetiracetam · Tablet · 10*s PKR 47.96/tablet-49.0% vs market median Lorymed 250 mgLevetiracetam · Tablet · 10*s PKR 28.88/tablet-47.7% vs market median Lorymed 500 mgLevetiracetam · Tablet · 30*s PKR 51.60/tablet-45.1% vs market median Lorymed 250 mgLevetiracetam · Tablet · 30*s PKR 31.12/tablet-43.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Pharmasol (Pvt) Ltd.251 products · 101 generics 26shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 26shared generics Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 24shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 24shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 23shared generics Bio-Labs(Pvt) Ltd234 products · 82 generics 23shared generics
Regulatory & price activity

Observed database signals

Registration numbers60
Price-history records70
Products with price history5
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

65 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Acytov Aciclovir 200 mg/5 mL Oral suspension 60ml 115867 PKR 314.89 PKR 5.25/mL Near median
Acytov Aciclovir 400 mg Tablet 1*35's 115868 PKR 2,204.25 PKR 62.98/tablet 7% above median
Canowel Clotrimazole 500 mg Tablet 1's 033084 PKR 120.87 PKR 120.87/tablet Near median
Canowel-V (with applicator Clotrimazole 20 mg/g Cream 35mg 115895 PKR 172.16 — No comparator
Diobest w/w Terbinafine 1 % Cream 10mg 087451 PKR 280.67 — No comparator
Flucowel Fluconazole 150 mg Capsule 1's 033079 PKR 324.83 PKR 324.83/capsule 24% above median
Flucowel Fluconazole 50 mg/5 mL Dry suspension 35ml 088656 PKR 402.27 PKR 11.49/mL Near median
Fluxewel Fluoxetine 20 mg Capsule 10's 033080 PKR 122.75 PKR 12.28/capsule 5% below median
Foskina Mupirocin 2 % Cream 15g 117893 PKR 263.32 PKR 17.55/g 9% below median
Gyrocin Moxifloxacin 400 mg Tablet 1*5's 096213 PKR 909.88 PKR 181.98/tablet Near median
Letwal Letrozole 2.5 mg Tablet 3*10 101162 PKR 7,116.66 PKR 237.22/tablet 41% below median
Linzomed Linezolid 600 mg Tablet 1*12's 096900 PKR 5,030.32 PKR 419.19/tablet 7% above median
Liwel Levofloxacin 250 mg Tablet 1*10's 035234 PKR 472.14 PKR 47.21/tablet Near median
Liwel Levofloxacin 500 mg Tablet 10's 035235 PKR 785.64 PKR 78.56/tablet Near median
Llinzomed 100/5ml Linezolid 100 mg/5 mL Dry suspension 60ml 088654 PKR 670.45 PKR 11.17/mL 5% above median
Lorymed Levetiracetam 500 mg Tablet 30*s 108533 PKR 1,547.87 PKR 51.60/tablet 45% below median
Lorymed Levetiracetam 250 mg Tablet 30*s 110110 PKR 933.47 PKR 31.12/tablet 44% below median
Lorymed Levetiracetam 500 mg Tablet 10*s 108533 PKR 479.60 PKR 47.96/tablet 49% below median
Lorymed Levetiracetam 250 mg Tablet 10*s 110110 PKR 288.79 PKR 28.88/tablet 48% below median
Lozemed Omeprazole 20 mg Capsule 14's 033093 PKR 271.95 PKR 19.43/capsule Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.